ADVERTISEMENT

Tatva Chintan Pharma Chem Q3 Results Review - SDA Revenue Recovers; But Margins Dip: ICICI Securities

Tatva's Q3 revenue rose 15% YoY / 34% QoQ to Rs 1.2 billion as structure directing agents revenue recovered to Rs 0.6 bn.

<div class="paragraphs"><p>Scientist testing a chemical solutions in test tubes in R&amp;D lab. (Source: freepik)</p></div>
Scientist testing a chemical solutions in test tubes in R&D lab. (Source: freepik)
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy. 
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More